Skip to main content
. 2023 Sep 18;41(12):3421–3427. doi: 10.1007/s00345-023-04583-w

Table 2.

List of all assessed variants and the results obtained from ddPCR analysis of tumour cell DNA (one sample/patient) and cfDNA in plasma from each patient. Each patient had at least one plasma sample and two variants were analysed for each sample and shown in separate rows. If multiple plasma samples were available from a patient, the results are shown as additional rows

ID Variant Tumour cell DNA False positive rate Plasma cfDNA Total cfDNA
Mutant VAF (%) VAF (%) Mutant
VAF (%)
Mutant
Copies/mL
WT
Copies/mL
Variant result Sample result Copies/mL
PP-1 KMT2D c.15517G > T 7 0 0 0 4177 Negative Negative 9329
KMT2D c.6562delG 5 0.05 0 0 5152 Negative
KMT2D c.15517G > T 0 0 1396 Negative Negative 3105
KMT2D c.6562delG 0 0 1709 Negative
PP-2 KDM6A c.1663C > T 5 0 0 0 483 Negative Negative 1422
TERT C228T 4 0.07 0.04 0 939 Negative
KDM6A c.1663C > T 0 0 777 Negative Negative 2262
TERT C228T 0 0 1485 Negative
PP-3 KDM6A c.3373dupA 20 0.03 0 0 753 Negative Negative 3502
FGFR3 c.1118A > G 17 0 0 0 2749 Negative
PP-5 HRAS c.351G > C 9 0 0 0 2105 Negative Negative 4557
TERT C228T 6 0 0 0 2452 Negative
PP-6 TP53 c.326 T > C 19 0 4 217 5767 Positive Positive 12477
PIK3CA c.1633G > C 7 0 1 83 6410 Positive
PP-4 KMT2C c.4432C > T 22 0.02 0.03 1 2079 Negative Positive 4744
TERT C228T 20 0.02 24 645 2020 Positive
PP-8 TSC1 c.2507C > G 24 0 1 14 1037 Positive Positive 2052
TERT C228T 21 0.02 1 9 993 Positive
PP-7 KDM6A c.3293delT 27 0 0 0 630 Negative Negative 1740
TERT C228T 14 0.05 0 0 1110 Negative
KDM6A c.3293delT 0 0 947 Negative Negative 2418
TERT C228T 0 0 1471 Negative
KDM6A c.3293delT 0.4 3 822 Positive Positive 2103
TERT C228T 0.3 4 1274 Positive
PP-9 ELF3 c.740G > A 19 0.02 0 0 3931 Negative Positive 7943
KMT2D c.11024delG 12 0.05 0.2 8 4004 Positive

VAF variant allele frequency; wt wild type